Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: William Welch, Dirk van den Boom, Ron Lindsay, Frederic Walder

Premium

Sequenom has promoted several members of its management team. William Welch is now the president and chief operating officer. He was previously senior vice president of diagnostics and has overseen the commercial operations of the MaterniT21 Plus test. Dirk van den Boom has been appointed executive vice president of research and development and chief technology officer from his position of senior vice president of research and development, which he has held since 2010. He joined the company in 1998. Ron Lindsay is now executive vice president of strategic planning. He was previously the executive vice president of research and development.


Fluidigm has named Frederic Walder to serve as its chief operating officer. Walder has been chief business officer at Fluidigm since 2010. From 1992 to 2010, Walder held various senior executive posts at Thermo Fisher Scientific.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.